Nonviral gene therapy with surfactants

ACS Symposium Series

Volumn 923, Issue , 2006, Pages 198-216

  Yadava, Preeti ^a   Buethe, David ^a   Hughes, Jeffrey A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36949015587     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2006-0923.ch014     Document Type: Conference Paper

References (88)

1. Horellou, P.; Mallet, J. Gene therapy for Parkinson's disease. Mol Neurobiol. 1997, 15, 241-56.
2. Roth, C.M.; Sundaram, S. Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. Annu Rev Biomed Eng. 2004, 6, 397-426.
3. Tenenbaum, L. et al. Recombinant AAV-mediated gene delivery to the central nervous system J Gene Med. 2004, 6 Suppl 1, S212-22.
4. Marti, W.R. et al. Recombinant vaccinia viruses as efficient vectors of biologically active, human B7 costimulation molecules. Langenbecks Arch Chir Suppl Kongressbd. 1998, 115 Suppl I, p. 131-6.
5. Kootstra, N.A.; Verma, I.M. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol. 2003, 43, 413-39.
6. Wilson, D.R. Viral-mediated gene transfer for cancer treatment. Curr Pharm Biotechnol. 2002, 3, 151-64.
7. Afonina, E.; Stauber, R.; Pavlakis, C.N. The human poly(A)-binding protein 1 shuttles between the nucleus and the cytoplasm. J Biol Chem. 1998, 273, 13015-21.
8. Tano, K., Foote, R.S.; Mitra, S. High-level expression of the cloned ada gene of Escherichia coli by deletion of its regulatory sequence. Gene 1988, 64, 305-11.
9. Poppe, C.; Gyles, C.L. Tagging and elimination of plasmids in Salmonella of avian origin. Vet Microbiol. 1988, 18, 73-87.
10. Ruiz, F.E. et al. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther. 2001, 12, 751-61.
11. Yew, N.S. et al. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther. 1999, 10, 223-34.
12. Hies, M.A., Seitz, W.A.; Balaban, A.T. Cationic lipids in gene delivery: principles, vector design and therapeutical applications. Curr Pharm Des. 2002, 8, 2441-73.
13. Stamatatos, L. et al. Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes. Biochemistry 1988, 27, 3917-25.
14. Zabner, J. et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 1995, 270, 18997-9007.
15. Wrobel, I.; Collins, D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta 1995, 1235, 296-304.
16. Zhou, X.; Huang, L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta 1994, 1189, 195-203.
17. El Ouahabi, A. et al. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett. 1997, 414, 187-92.
18. Wattiaux, R. et al. Cationic lipids destabilize lysosomal membrane in vitro. FEBS Lett. 1997, 417, 199-202.
19. Singh, M. et al. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance. Pharm Res. 2003, 20, 247-51.
20. Felgner, P.L. et al. Lipofection: a highly efficient, lipid-mediated DNAtransfection procedure. Proc Natl Acad Sci USA 1987, 84, 7413-7.
21. Lardans, V. et al. DNA transfer in a Biomphalaria glabrata embryonic cell line by DOTAP lipofection. Parasitol Res. 1996, 82, 574-6.
22. Behr, J.P. et al. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 1989, 86, 6982-6.
23. Hofland, H.E.; Shephard, L.; Sullivan, S.M. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA 1996, 93, 7305-9.
24. Mason, J.T.; O'Leary, T.J. Effects of headgroup methylation and acyl chain length on the volume of melting of phosphatidylethanolamines. Biophys J. 1990, 58, 277-81.
25. Lasic, D.D.; Papahadjopoulos, D. Liposomes revisited. Science 1995, 267, 1275-6.
26. Dauty, E. et al. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J Am Chem Soc. 2001, 123, 9227-34.
27. Herscovici, J. et al. Synthesis of new cationic lipids from an unsaturated glycoside scaffold. Org Lett. 2001, 3, 1893-6.
28. Belmont, P. et al. Aminoglycoside-derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo. J Gene Med. 2002, 4, 51726.
29. Tang, M.X.; Redemann, C.T.; Szoka, Jr., F.C. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem. 1996, 7, 703-14.
30. Bielinska, A.U. et al. DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug Chem. 1999, 10, 843-50.
31. Hies, M.A. et al. Pyridinium cationic lipids in gene delivery: a structureactivity correlation study. J Med Chem. 2004, 47, 3744-54.
32. van der Woude, I. et al. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc Natl Acad Sci USA 1997, 94, 1160-5.
33. Yang, K. et al. DC-Chol liposome-mediated gene transfer in rat spinal cord. Neuroreport 1997, 8, 2355-8.
34. Kawakami, S. et al. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem Biophys Res Commun. 1998, 252, 78-83.
35. Bessodes, M. et al. Synthesis and biological properties of new glycosidic cationic lipids for DNA delivery. Bioorg Med Chem Lett. 2000, 10, 1393-5.
36. Bhattacharya, S.; Dileep, P.V. Cationic oxyethylene lipids. Synthesis, aggregation, and transfection properties. Bioconjug Chem. 2004, 15, 508-19.
37. Dileep, P.V.; Antony, A.; Bhattacharya, S. Incorporation of oxyethylene units between hydrocarbon chain and pseudoglyceryl backbone in cationic lipid potentiates gene transfection efficiency in the presence of serum. FEBS Lett. 2001, 509, 327-31.
38. Oupicky, D., Carlisle, R.C.; Seymour, L.W. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther. 2001, 8, 713-24.
39. Baker, A. et al. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther. 1997, 4, 773-82.
40. Trubetskoy, V.S. et al. Use of N-terminal modified poly(L-lysine)- antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. Bioconjug Chem. 1992, 3, 323-7.
41. Trubetskoy, V.S. et al. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(Llysine)- antibody conjugate in mouse lung endothelial cells. Biochim Biophys Acta 1992, 1131, 311-3.
42. Hashida, M. et al. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). J Control Release 1998, 53, 301-10.
43. Sorgi, F.L.; Bhattacharya, S.; Huang, L. Protamine sulfate enhances lipidmediated gene transfer. Gene Ther. 1997, 4, 961-8.
44. Erbacher, P. et al. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res. 1998, 15, 1332-9.
45. Liu, M.; Frechet, J.M.J. Designing dendrimers for drug delivery. Pharma Sci Technol Today 1999, 2, 393-401.
46. Malik, N. et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 1251labelled polyamidoamine dendrimers in vivo. J Control Release 2000, 65, 133-48.
47. Hafez, I.M.; Ansell, S.; Cullis, P.R. Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys J. 2000, 79, 1438-46.
48. Jordanova, A.; Lalchev,.; Tenchov, B. Formation of monolayers and bilayer foam films from lamellar, inverted hexagonal and cubic lipid phases. Eur Biophys J. 2003, 31, 626-32.
49. Rappolt, M. et al. Mechanism of the lamellar/inverse hexagonal phase transition examined by high resolution x-ray diffraction. Biophys J. 2003, 84, 3111-22.
50. Hafez, I.M.; Maurer, N.; Cullis, P.R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 2001, 8, 1188-96.
51. Haas, D.H.; Murphy, R.M. Templated assembly of the pH-sensitive membrane-lytic peptide GALA. JPept Res. 2004, 63, 451-9.
52. Liang, E. et al. Biodegradable pH-sensitive surfactants (BPS) in liposomemediated nucleic acid cellular uptake and distribution. Eur J Pharm Sci. 2000, 11, 199-205.
53. Liu, Y. et al. Factors influencing the efficiency of cationic liposomemediated intravenous gene delivery. Nat Biotechnol. 1997, 15, 167-73.
54. Liu, F. et al. New cationic lipid formulations for gene transfer. Pharm Res. 1996, 13, 1856-60.
55. Remy-Kristensen, A. et al. Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA complexes. Biochim Biophys Acta 2001, 1514, 21-32.
56. Xu, Y.; Szoka, Jr., F.C. Mechanism of DNA release from cationic liposome/ DNA complexes used in cell transfection. Biochemistry 1996, 35, 5616-23.
57. Siegel, D.P.; Epand, R.M. The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms. Biophys J. 1997, 73, 3089-111.
58. Ellens, H. et al. Membrane fusion and inverted phases. Biochemistry 1989, 28, 3692-703.
59. Pinnaduwage, P.; Schmitt, L.; Huang, L. Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. Biochim Biophys Acta 1989, 985, 33-7.
60. Smisterova, J. et al. Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery. J Biol Chem. 2001, 276, 47615-22.
61. Koltover, I. et al. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 1998, 281, 78-81.
62. Hafez, I.M.; Cullis, P.R. Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev. 2001, 47, 139-48.
63. Fielden, M.L. et al. Sugar-based tertiary amino gemini surfactants with a vesicle-to-micelle transition in the endosomal pH range mediate efficient transfection in vitro. Eur J Biochem 2001, 268, 1269-79.
64. Israelachvili, J.N.; Marcelja, S.; Horn, R.G. Physical principles of membrane organization. Q Rev Biophys. 1980, 13, 121-200.
65. Felgner, P.L. et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther. 1997, 8, 511-2.
66. Denis-Mize, K.S. et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther. 2000, 7, 2105-12.
67. Lleres, D. et al. Dependence of the cellular internalization and trans-fection efficiency on the structure and physicochemical properties of cationic detergent/DNA/liposomes. J Gene Med. 2004, 6, 415-28.
68. Petrov, A.I.; Zhdanov, R.I. Complexation of DNA with cationic surfactant CTAB. UV-melting and fluorescent study. in 35th IUPAC Congress 1995, 97.
69. Petrov, A.I.; Arslan, A.; Zhdanov, R. DNA interaction with cationic surfactants: DNA-CTAB complex. in 35th IUPAC Congress 1995.
70. Tang, F.; Hughes, J.A. Synthesis of a single-tailed cationic lipid and investigation of its transfection. J Control Release 1999, 62, 345-58.
71. Ogris, M. et al. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS PharmSci. 2001, 3, E21.
72. Jaaskelainen, I. et al. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides. Eur J Pharm Sci. 2000, 10, 187-93.
73. Lee, L.K. et al. Biophysical characterization of an integrin-targeted nonviral vector. Med Sci Monit. 2003, 9, BR54-61.
74. Xu, Y. et al. Physicochemical characterization and purification of cationic lipoplexes. Biophys J, 1999, 77, 341-53.
75. Felgner, J.H. et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem. 1994, 269, 2550-61.
76. Ross, P.C.; Hui, S.W. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. 1999, 6, 651-9.
77. Kennedy, M.T. et al. Factors governing the assembly of cationic phospholipid-DNA complexes. Biophys J. 2000, 78, 1620-33.
78. Devine, D.V. et al. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta 1994, 1191, 43-51.
79. Liu, D.; Liu, F.; Song, Y.K. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim Biophys Acta 1995, 1235, 140-6.
80. Senior, J.; Crawley, J.C.; Gregoriadis, G. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta 1985, 839, 1-8.
81. Litzinger, D.C. et al. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic polyethylene glycol)-containing liposomes. Biochim Biophys Acta 1994, 1190, 99-107.
82. Niven, R.; Zhang, Y.; Smith, J. Toward development of a non-viral gene therapeutic. Adv Drug Deliv Rev. 1997, 26, 135-150.
83. Artzner, F.; Zantl, R.; Radler, J.O. Lipid-DNA and lipid-polyelectrolyte mesophases: structure and exchange kinetics. Cell Mol Biol (Noisy-legrand) 2000, 46, 967-78.
84. Lee, RJ.; Huang, L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem. 1996, 271, 8481-7.
85. Dauty, E.; Behr, J.P.; Remy, J.S. Development of plasmid and oligonucleotide nanometric particles. Gene Ther. 2002, 9, 743-8.
86. Blessing, T.; Remy, J.S.; Behr, J.P. Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci USA 1998, 95, 1427-31.
87. Stella, B. et al. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci. 2000, 89, 1452-64.
88. Ward, C.M.; Acheson, N.; Seymour, L.W. Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients. J Drug Target 2000, 8, 119-23.